Neoadjuvant therapy in breast cancer as a basis for drug approval

Donald A. Berry; Clifford A. Hudis

doi:10.1001/jamaoncol.2015.1293

Neoadjuvant therapy in breast cancer as a basis for drug approval

Donald A. Berry, Clifford A. Hudis

Biostatistics

Research output: Contribution to journal › Short survey › peer-review

41 Scopus citations

Original language	English (US)
Pages (from-to)	875-876
Number of pages	2
Journal	JAMA Oncology
Volume	1
Issue number	7
DOIs	https://doi.org/10.1001/jamaoncol.2015.1293
State	Published - Oct 2015

ASJC Scopus subject areas

Oncology
Cancer Research

MD Anderson CCSG core facilities

Biostatistics Resource Group

Access to Document

10.1001/jamaoncol.2015.1293

Cite this

@article{4a36a9a6ac864af296d7ab198a867bd8,

title = "Neoadjuvant therapy in breast cancer as a basis for drug approval",

author = "Berry, {Donald A.} and Hudis, {Clifford A.}",

year = "2015",

month = oct,

doi = "10.1001/jamaoncol.2015.1293",

language = "English (US)",

volume = "1",

pages = "875--876",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "7",

}

TY - JOUR

T1 - Neoadjuvant therapy in breast cancer as a basis for drug approval

AU - Berry, Donald A.

AU - Hudis, Clifford A.

PY - 2015/10

Y1 - 2015/10

UR - http://www.scopus.com/inward/record.url?scp=84965094393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965094393&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2015.1293

DO - 10.1001/jamaoncol.2015.1293

M3 - Short survey

C2 - 26181139

AN - SCOPUS:84965094393

SN - 2374-2437

VL - 1

SP - 875

EP - 876

JO - JAMA Oncology

JF - JAMA Oncology

IS - 7

ER -

Neoadjuvant therapy in breast cancer as a basis for drug approval

ASJC Scopus subject areas

MD Anderson CCSG core facilities

Access to Document

Other files and links

Cite this